Proteus Digital Health is leveraging medtech, pharma, wireless technology, wearable technology, cloud computing, and mobile health to solve one of the biggest problems in healthcare: how to get patients to comply with their medication regimen.
The company’s FDA-cleared ingestible sensor, coupled with a wireless patch, can track when patients take their pills or if they miss a dose, as well as collect information on heart rate, respiration rate, and activity. That data can be shared with family members, caregivers, and physicians via the cloud.
Investors are noticing, too. This year, they pumped in a whopping $172 million in a Series G funding round.
In October, Proteus announced a collaboration with Oracle by which pharmaceutical companies can avail of a cloud-based service that can improve the odds of success for Phase III clinical trials. Designing those trials requires correctly estimating the medication adherence patterns of patients—and that is Proteus’s strong suit.